Related Experiment Video
Updated: Mar 9, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
How Can We Treat Cancer Disease Not Cancer Cells?
Kyu-Won Kim1, Su-Jae Lee2, Woo-Young Kim3
1SNU-Harvard NeuroVascular Protection Research Center, College of Pharmacy, Seoul National University, Seoul, Korea.
Abstract:
Since molecular biology studies began, researches in biological science have centered on proteins and genes at molecular level of a single cell. Cancer research has also focused on various functions of proteins and genes that distinguish cancer cells from normal cells. Accordingly, most contemporary anticancer drugs have been developed to target abnormal characteristics of cancer cells. Despite the great advances in the development of anticancer drugs, vast majority of patients with advanced cancer have shown grim prognosis and high rate of relapse. To resolve this problem, we must reevaluate our focuses in current cancer research. Cancer should be considered as a systemic disease because cancer cells undergo a complex interaction with various surrounding cells in cancer tissue and spread to whole body through metastasis under the control of the systemic modulation. Human body relies on the cooperative interaction between various tissues and organs, and each organ performs its specialized function through tissue-specific cell networks. Therefore, investigation of the tumor-specific cell networks can provide novel strategy to overcome the limitation of current cancer research. This review presents the limitations of the current cancer research, emphasizing the necessity of studying tissue-specific cell network which could be a new perspective on treating cancer disease, not cancer cells.
Insights
Current cancer research focuses on single cells, but cancer is a systemic disease. Studying tissue-specific cell networks offers a new strategy for treating cancer effectively.
Area of Science:
- Molecular Biology
- Oncology
- Systems Biology
Background:
- Traditional cancer research and drug development focus on molecular differences between cancer and normal cells.
- Despite advances, advanced cancer patients often face poor prognosis and high relapse rates, indicating limitations in current approaches.
Purpose of the Study:
- To highlight the limitations of single-cell-focused cancer research.
- To advocate for a paradigm shift towards understanding cancer as a systemic disease.
- To emphasize the potential of investigating tissue-specific cell networks for novel cancer treatment strategies.
Main Methods:
- This is a review article, synthesizing existing knowledge.
- It analyzes the limitations of current molecular-level cancer research.
- It proposes a systems biology approach focusing on intercellular interactions.
Main Results:
- Current research paradigms targeting cancer cell-specific molecules have yielded limited success in advanced stages.
- Cancer involves complex interactions between tumor cells and their surrounding microenvironment.
- Systemic modulation influences metastasis and disease progression.
Conclusions:
- Viewing cancer as a systemic disease, rather than solely a cellular one, is crucial for progress.
- Investigating tumor-specific cell networks provides a novel perspective for therapeutic development.
- A shift towards understanding tissue-specific cell networks could overcome current treatment limitations.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

